"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Jubilant Pharmova Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs	Chairman : Shyam S Bhartia
Home : Jubilant Bhartia	Book Value: 145.519774
BSE Code : 530019	Market Cap: 18231.89
NSE Code : JUBLPHARMA	P / E : 0

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Type	1Qtr	4Qtr	3Qtr	2Qtr
Net Sales	59.50	60.50	193.40	162.60
Other Income	2.40	13.00	18.40	43.80
Total Income	61.90	73.70	214.40	209.50
Total Expenditure	49.20	49.80	185.00	171.80
Operating Profit	12.70	23.90	29.40	37.70
Interest	3.00	3.10	7.40	7.80
Gross Profit	9.70	20.80	22.00	29.90
Depreciation	1.50	1.50	13.30	13.30
Tax	1.20	5.00	6.30	5.30
Deferred Tax	1.20	0.70	-2.90	0.80
Reported Profit After Tax	5.80	13.60	5.30	10.50

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView